Monthly Archives: September 2008

Dr. Philippe Sarret Team and Potential New Pain Targets

Shedding Light on New Pain Pathways

There is no joy in Painville. Our answer to pain is: “make it go away”! It spoils quality of life. The socio-economic costs for treatments, loss of productivity and absenteeism, are measured in billions USD$.
Today, moderate to severe pain is treated mostly with NSAIDs, narcotics or tricyclics (anti-depressants). Properly prescribed, [...]

Stem Cell Research Guidelines Sidebar

As a growing provider of Stem Cell Research Reagents, I am in search of information that cuts through the confusion. My goal is to publish postings that could be of value to my customers and researchers.
On September 5th, Updated Guidelines for Stem Cell Research was released by the National Academies.
One reason for the 2008 modifications is [...]

Making Gains on Pain

Neuromics has been helping researchers make “gains on pain” from day one. Our initial sales were Opioid Receptor Antibdies licensed from Dr. Robert Elde’s lab at the University of Minnesota.
From this start, we have expanded our expertise and products. Our reputation in this area has resulted in our forming collaborations and friendships with research teams doing [...]

Umbilical-Cord Matrix Stem Cells and Cerebral Ischemia

I am winding down on the stem cell story for now as later in the month I will be featuring my good friends at University of Sherbrooke and their research in the area of chronic pain.
I did want to highlight yet another potential application for stem cells. For this, we send kudos to Dr. Yan Xu [...]